Evidence map›Paper›PMID 26306134›Full record

ArticleMethodist DeBakey cardiovascular journal

Case Report: En Bloc Resection of Pancoast Tumor with Adjuvant Aortic Endograft and Chemoradiation.

Tony Lu, Uwe M Fischer, Rex A Marco, Joseph J Naoum, Michael J Reardon, Alan B Lumsden, Shanda H Blackmon, Mark G Davies

Open access · diamondAbstract readCase Reports
In one paragraph

Article in Methodist DeBakey cardiovascular journal. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 88% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Tony LuHouston Methodist DeBakey Heart& Vascular Center, Houston Methodist Hospital, Houston, Texas.
Uwe M FischerHouston Methodist DeBakey Heart& Vascular Center, Houston Methodist Hospital, Houston, Texas.
Rex A MarcoThe University of Texas Medical School at Houston, Houston, Texas.
Joseph J NaoumHouston Methodist DeBakey Heart& Vascular Center, Houston Methodist Hospital, Houston, Texas.
Michael J ReardonHouston Methodist DeBakey Heart& Vascular Center, Houston Methodist Hospital, Houston, Texas.
Alan B LumsdenHouston Methodist DeBakey Heart& Vascular Center, Houston Methodist Hospital, Houston, Texas.
Shanda H BlackmonHouston Methodist Hospital, Houston, Texas.
Mark G DaviesHouston Methodist DeBakey Heart& Vascular Center, Houston Methodist Hospital, Houston, Texas.
Methodist Hospital · USMethodist Hospital · USHouston Methodist · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

"Pancoast" tumors frequently require a multidisciplinary approach to therapy and are still associated with high morbidity and mortality. Due to their sensitive anatomic location, complex resections and chemoradiation regimens are typically required for treatment. Those with signs of aortic invasion pose an even greater challenge, given the added risks of cardiopulmonary bypass for aortic resection and interposition. Placement of an aortic endograft can facilitate resection if the tumor is in close proximity to or is invading the aorta. Prophylactic endografting to prevent radiation-associated aortic rupture has also been described. This case describes a 60-year-old female who presented with a stage IIIa left upper lobe undifferentiated non-small-cell carcinoma encasing the subclavian artery with thoracic aorta and bony invasion. Following carotid-subclavian bypass with Dacron, en bloc resection of the affected lung, ribs, and vertebral bodies was performed. The aorta was prophylactically reinforced with a Gore TAG thoracic endograft prior to adjuvant chemoradiation. The patient remains disease-free at more than 5 years follow-up after completing her treatment course. Endovascular stenting with subsequent chemoradiation may prove to be a viable alternative to palliation or open operative management and prevention of aortic injury during tumor resection and/or adjuvant therapy in select patients with aortic involvement.

Indexed as

Blood Vessel ProsthesisChemoradiotherapy, AdjuvantPneumonectomyAorta, ThoracicBlood Vessel Prosthesis ImplantationCarcinoma, Non-Small-Cell LungEndovascular ProceduresFemaleHumansLung NeoplasmsMagnetic Resonance ImagingMiddle AgedNeoplasm StagingPancoast SyndromePolyethylene TerephthalatesProsthesis DesignPolyethylene Terephthalatesnon-small cell lung cancerPancoast tumorthoracic endovascular aneurysm repair

Identifiers

PMID26306134
PMCPMC4547671
OpenAlexW2205833906

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.